Harm reduction

Harm reduction treats survival, dignity, and access to care as urgent goals even when a person is not ready or able to stop using drugs. In the book, it is both a practical set of interventions—clean syringes, naloxone, supervised injection, and drug checking—and a challenge to systems that make abstinence the price of help. Its significance lies in the distinction between ending drug use and preventing the avoidable deaths and illness that can occur while drug use continues.

Principles and Practice

The approach described in Vancouver is grounded in reducing the negative consequences of drug use without requiring that use to end first. Its public-health logic is direct: people must remain alive to pursue recovery, and preventing infection can be more humane and less costly than treating it later. Vancouver’s services combined supervised injection sites, where nurses could respond to overdoses, with exchanges of used syringes for clean ones and naloxone distribution. These measures addressed immediate risks while treating users as people entitled to care rather than as problems to be removed from public view.

Harm reduction also changes what counts as a useful point of contact. In San Francisco, Seattle, Philadelphia, and Greensboro, drug-user unions organized against the stigma surrounding addiction and advocated for wider naloxone access and needle exchanges. Their work could include negotiating with dealers when fentanyl-contaminated supplies appeared. The effort thus reached beyond clinical treatment: it treated the knowledge and participation of people who use drugs as essential to responding to danger in local drug markets. Advocates also pressed treatment providers to be accountable for the care they offered, including whether they made medication-assisted treatment available.

Drug checking offers another example of reducing risk without claiming to eliminate it. In Massachusetts, prevention workers piloted fentanyl test strips so users could assess a drug’s potency before taking it. That information could help them consider a smaller dose, avoid using alone, and keep naloxone available. Boston residents carrying naloxone kits sometimes marked their backpacks with purple ally patches, signaling that they could respond to an overdose. The patch made preparedness visible in public: overdose response was not confined to professionals or institutions.

Services, Access, and Evidence

Baltimore’s health department brought services directly to places where heroin use was concentrated, deploying a needle-exchange recreational vehicle six days a week. It offered clean syringes alongside disease testing, naloxone training, wound care, and prenatal care. The initiative was credited with reducing needle-injected HIV instances from 64 to 8 percent. The model linked prevention to a range of health needs rather than limiting contact to the distribution of equipment, and it brought support to people who might not otherwise reach a clinic.

The response to the HIV outbreak in Scott County, Indiana, illustrates the pressure that an emergency can place on political opposition. The outbreak infected 175 people before then-governor Mike Pence reluctantly authorized a limited needle exchange. A year later, HIV cases in the county had plateaued at around 210. The book places this intervention beside approaches that were already more established elsewhere, making clear that syringe exchange could become politically possible under crisis conditions even where it had previously faced resistance.

The evidence also complicates claims that exchanges simply create disorder. Early results from the Huntington needle-exchange program in West Virginia were positive. Even a bare-bones exchange operating on about $10,000 a year could be cost-effective when compared with treating a single hepatitis C infection, which could cost between $65,000 and $500,000. In other localities, police officers’ needle-stick injuries were reported 66 percent less often. These findings present exchange programs not only as a health measure for people who inject drugs but also as a way to reduce costs and risks borne by the wider community.

The book sets these interventions against a treatment landscape with substantial barriers. Only about one-third of U.S. treatment centers allowed medication-assisted treatment, and there was only one treatment bed for every five people seeking rehabilitation. Care was often too expensive for people without adequate insurance. This mattered especially to people such as Tess Henry, whose buprenorphine helped her feel normal and prevented withdrawal and cravings, while appointments with her addiction doctor remained cash-only and could require repeated payments. Harm reduction and medication-assisted treatment are not identical approaches, but the book shows how both can be blocked by the same shortage of affordable, accessible, evidence-based care.

Trust and Low-Threshold Care

The Supportive Place for Observation and Treatment, known as SPOT, shows how harm reduction could reshape the first encounter between a service and someone in crisis. After more than fifty neighborhood meetings, Jessie Gaeta secured reluctant local support by showing community leaders and officials the small room, which had ten recliners. The program did not keep patients’ names on file, a low-threshold practice intended to build trust. Staff monitored people who arrived after using heroin with a growing mixture of other drugs, responding to problems already present in the neighborhood rather than demanding that people first qualify as abstinent patients.

That trust could make other forms of care possible. At SPOT, skittish survivors of sexual assault accepted preventive treatment for sexually transmitted infections and began telling staff what had happened to them. The account makes low-threshold care more than an administrative policy: privacy and a nonjudgmental point of entry could allow someone to seek help before they were prepared to enter conventional treatment. Gaeta’s experience also reveals the resistance such work faced, including within organizations that understood themselves as serving a mission. The persistent question was whether care should extend to people who did not want treatment, or whether their refusal disqualified them from support.

Tracey Helton Mitchell developed another form of direct, informal access. After recovering from heroin addiction and becoming a certified addiction specialist, she began mailing free packages of clean needles and naloxone vials in 2003. In an online forum for people concerned with heroin use, she shared counseling and intervention strategies and answered about fifty emails a day. She continued to receive calls from users across broad areas of the country seeking clean needles, information, and naloxone. Her work responded to gaps that formal services had left open, including places where people lacked safe injection equipment and reliable guidance.

Political and Social Stakes

Harm reduction stands in sharp contrast to a criminal-justice response that treats punishment as the primary answer to drug use. The book describes the widening divide between families seeking treatment and officials who argued for severe prison sentences for heroin users. That divide also had a racial dimension. Heroin in Roanoke had long been regarded as an inner-city, Black drug and was treated as a largely invisible problem. Later, opioid use among predominantly white users was often discussed as a public-health crisis, while Black and brown people arrested for drug selling remained more likely to face punitive enforcement. The book notes that doctors prescribed painkillers to people of color at substantially lower rates than to white patients, a disparity that appeared to limit exposure to one route into opioid addiction while criminal enforcement remained unequal. Harm reduction’s insistence on care for people who use drugs therefore sits within a broader conflict over whose drug use is treated as illness and whose is treated as crime.

The same account locates the crisis in conditions beyond individual behavior. In rural counties damaged by globalization, automation, and coal’s decline, unemployment, food insecurity, and disability claims rose. The book identifies the collapse of work alongside expanding painkiller supplies as a combined force in the epidemic. These conditions do not replace the need for immediate measures such as naloxone and clean syringes; they help explain why a response limited to policing or individual treatment cannot meet the full scale of the problem. Harm reduction addresses urgent risks while raising the question of whether communities can also restore the work, relationships, and resources that make lives beyond drug use possible.

In Virginia, the state health commissioner declared an opioid public-health emergency in late 2016, citing three overdose deaths a day and more than two dozen overdose cases each day in emergency departments. A standing order then allowed residents to obtain naloxone. This expansion of access belonged to the same practical logic as other harm-reduction measures: make an effective response available before an overdose becomes a death. Yet the book’s examples—from Baltimore’s mobile services to SPOT’s low-threshold room and Mitchell’s informal outreach—show that a policy announcement alone cannot supply enough treatment, remove financial barriers, or guarantee trust. Harm reduction is presented not as a cure-all but as an immediate, evidence-backed commitment to keep people alive and within reach of care.